BridgeBio Pharma

Drug prices

Pharma

Pfizer's ATTR drug again faces pricing scrutiny

Pfizer’s tafamidis needs a minimum 85% discount from its annual list price to meet commonly accepted cost-effectiveness thresholds, ICER says.

Angus Liu Oct 21, 2024 2:55pm

European Medicines Agency

CHMP blesses 11 new drugs but says no to Clovis' Rubraca

Jul 22, 2022 9:55am

Len Schleifer

With $453M, Regeneron's Schleifer tops biopharma's realized pay

Jul 18, 2022 11:17am